Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Assets (2020 - 2025)

Celularity has reported Assets over the past 6 years, most recently at $114.2 million for Q3 2025.

  • Quarterly results put Assets at $114.2 million for Q3 2025, down 11.33% from a year ago — trailing twelve months through Sep 2025 was $114.2 million (down 11.33% YoY), and the annual figure for FY2024 was $132.7 million, down 7.79%.
  • Assets for Q3 2025 was $114.2 million at Celularity, down from $120.3 million in the prior quarter.
  • Over the last five years, Assets for CELU hit a ceiling of $448.3 million in Q3 2021 and a floor of $114.2 million in Q3 2025.
  • Median Assets over the past 5 years was $157.2 million (2023), compared with a mean of $252.6 million.
  • Biggest five-year swings in Assets: soared 234.33% in 2022 and later crashed 64.12% in 2023.
  • Celularity's Assets stood at $414.1 million in 2021, then fell by 3.15% to $401.1 million in 2022, then crashed by 64.12% to $143.9 million in 2023, then dropped by 7.79% to $132.7 million in 2024, then fell by 13.9% to $114.2 million in 2025.
  • The last three reported values for Assets were $114.2 million (Q3 2025), $120.3 million (Q2 2025), and $128.9 million (Q1 2025) per Business Quant data.